Compare LOW & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LOW | BMY |
|---|---|---|
| Founded | 1946 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 133.5B | 111.3B |
| IPO Year | N/A | N/A |
| Metric | LOW | BMY |
|---|---|---|
| Price | $244.41 | $54.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 13 |
| Target Price | ★ $277.40 | $56.31 |
| AVG Volume (30 Days) | 2.8M | ★ 16.2M |
| Earning Date | 11-19-2025 | 02-05-2026 |
| Dividend Yield | 1.96% | ★ 4.61% |
| EPS Growth | ★ 0.73 | N/A |
| EPS | ★ 12.06 | 2.97 |
| Revenue | ★ $84,255,000,000.00 | $48,034,000,000.00 |
| Revenue This Year | $3.89 | $0.27 |
| Revenue Next Year | $8.27 | N/A |
| P/E Ratio | $20.27 | ★ $18.39 |
| Revenue Growth | 0.64 | ★ 1.26 |
| 52 Week Low | $206.39 | $42.52 |
| 52 Week High | $274.98 | $63.33 |
| Indicator | LOW | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 52.67 | 69.18 |
| Support Level | $239.54 | $54.01 |
| Resistance Level | $254.04 | $54.86 |
| Average True Range (ATR) | 4.42 | 1.06 |
| MACD | -0.59 | 0.05 |
| Stochastic Oscillator | 34.28 | 89.49 |
Lowe's is the second-largest home improvement retailer globally, with around 1,750 stores in the US, after the 2023 divestiture of its Canadian locations (RONA, Lowe's Canada, Réno-Dépôt, and Dick's Lumber). The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two-thirds of products sold. Lowe's primarily targets retail do-it-yourself (around 70% of sales) and do-it-for-me customers, but has expanded its professional business clients to 30% from less than 20% in the past six years (set ot expand further with the acquisition of FBM). We estimate Lowe's captures a high-single-digit share of the domestic home improvement market, based on US Census data and management's market size estimates.
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.